Marksans Pharma Limited (NSE:MARKSANS)
India · Delayed Price · Currency is INR 183.44
-0.26 (-0.14%)
Oct 30, 2025, 3:30 PM IST
Marksans Pharma Market Cap
Marksans Pharma has a market cap or net worth of 83.13 billion as of October 30, 2025. Its market cap has decreased by -36.05% in one year.
Market Cap
83.13B
Enterprise Value
79.51B
Revenue
26.52B
Ranking
n/a
PE Ratio
23.70
Stock Price
183.44
Market Cap Chart
Since December 13, 2006, Marksans Pharma's market cap has increased from 3.65B to 83.13B, an increase of 2,176.52%. That is a compound annual growth rate of 17.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 83.25B | -38.08% |
| Dec 31, 2024 | 134.43B | 84.14% |
| Dec 29, 2023 | 73.00B | 210.96% |
| Dec 30, 2022 | 23.48B | -4.66% |
| Dec 31, 2021 | 24.63B | -0.80% |
| Dec 31, 2020 | 24.82B | 263.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.05T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.27T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.01T |
| Mankind Pharma | 993.30B |
| Fortis Healthcare | 797.99B |
| Alkem Laboratories | 649.48B |